OncLive SOSS

My Treatment Approach: Metastatic Melanoma - Episode 5

First-line Treatment Strategies for BRAF-Mutant Metastatic Melanoma: Unmet Needs

May 11, 2022

Michael Atkins, MD, Evan Lipson, MD

Dr Michael Atkins and Dr Evan Lipson highlight some of the current unmet needs in the treatment of patients with metastatic melanoma.

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time 0:00

EP. 1: The Current State of Metastatic Melanoma

EP. 2: First-line and Subsequent Treatment Strategies for Unresectable/Metastatic Melanoma: A Patient Profile

EP. 3: First-line Treatment Strategies for BRAF-Mutant Metastatic Melanoma: Ipilimumab & Nivolumab

EP. 4: First-line Treatment Strategies for BRAF-Mutant Metastatic Melanoma: BRAF/MEK Inhibitors

EP. 5: First-line Treatment Strategies for BRAF-Mutant Metastatic Melanoma: Unmet Needs

EP. 6: Frontline Trials for BRAF-Mutant Metastatic Melanoma: Relatlimab Plus Nivolumab

EP. 7: Second-line Treatment Strategies for BRAF-mutant Metastatic Melanoma: Patient Profile Revisited

EP. 8: Second-line Treatment Strategies for BRAF-mutant Metastatic Melanoma: Additional Patient Scenarios

EP. 9: Closing Remarks on the Treatment of Patients With Metastatic Melanoma

x